Endometrial cancer

There are 293 papers on endometrial cancer in aging research: 8 trials and 155 observational studies in people, 4 in animals, 5 in cells, 101 reviews. The newest story, Nov 8, 2026: “Estrogen exposure estimates linked to longer life expectancy”.

Disease

293 papers study it53 more mention it154 findings

17 new papers in 30 daysSee all 346 papers on endometrial cancer

At a glance

Human studies link higher biological-age residuals, obesity and later menopause with higher endometrial cancer risk. A survivor study links the disease with walking or balance problems but finds no clear link with falls. Hormone-therapy and GLP-1 receptor agonist associations point both ways across regimens, populations and comparators.

154 findings in 103 papers from 2012 to 2026, 28 of them since April 2026

“endometrial cancer (aIRR, 0.51; 95% CI, 0.45-0.59)”
Bariatric Surgery and Risk of Obesity-Related Cancer by Age and SexJAMA surgery2026doi:10.1001/jamasurg.2026.4798
  • Human trial8
  • Humans155
  • Animals4
  • Cells5
  • In silico14

Interventions

12

Tibolone

no changein humans1HR 0.9

1 study
  1. Tibolone was not clearly linked with endometrial cancer in humans (HR 0.9, 95% CI: 0.61-1.314).

    “Tibolone use was not associated with increased risk when used for four years or less (HR 0.9, 95% CI: 0.61-1.314)”

    Humans<=4 yearsfemales

    Association between type and duration of menopausal hormone therapy and endometrial cancer risk: A population-based study

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

More on Tibolone

Lactation

no changein humans1HR 0.95

1 study
  1. Lactation was not clearly linked with endometrial cancer in humans (HR 0.95, 95% CI: 0.84-1.08).

    “or endometrial (0.95 [0.84-1.08] per month)”

    Humansfemalesn = 6,880

    Associations Between Duration of Lactation and Maternal Risk of Obesity-Related Cancers-A Historical Birth Cohort Study

    Maternal & child nutrition

More on Lactation

Conjugated equine estrogens

no changein humans1

1 study
  1. Conjugated equine estrogens were not clearly linked with endometrial cancer in humans (0.84 (0.49-1.44)).

    “High-dose Premarin vaginal cream had an association of 0.84 (0.49-1.44) compared with EPT (HIRD).”

    Humansvaginal creamendometrium

    Incidence of endometrial cancer among postmenopausal women using vaginal estrogen compared to estrogen and progestin combination hormone therapy

    Menopause (New York, N.Y.)

More on Conjugated equine estrogens

Polychlorinated biphenyls

no changein humans1RR 1.11

1 study
  1. Polychlorinated biphenyls showed no clear effect on endometrial cancer in humans (RR = 1.11, 95% CI: 0.79-1.56).

    “No significant association was identified between PCBs exposure and endometrial cancer risk (RR = 1.11, 95% CI: 0.79-1.56)”

    Review

    Environmental endocrine disruptors and endometrial cancer risk: a systematic review and meta-analysis of cadmium and polychlorinated biphenyls, with emerging evidence on PFAS, phthalates, and bisphenols

    Frontiers in oncology

More on Polychlorinated biphenyls

Quercetin

downin reviews1

1 study
  1. Quercetin protects against endometrial cancer (uterine-related conditions).

    “evaluates published evidence from pre-clinical and clinical studies supporting quercetin's pleiotropic effects and potential therapeutic benefits for six uterine-related conditions”

    Reviewuterine-related conditions

    A Review of the Potential Therapeutic Benefits of Quercetin for Uterine-Related Conditions

    Biomedicines

More on Quercetin

Coffee

downin humans1

1 study
  1. Coffee protects against endometrial cancer in humans.

    “The epidemiological evidence suggests a protective effect of coffee towards postmenopausal breast and endometrial cancer.”

    Review

    COFFEE CONSUMPTION AND FEMALE CANCERS: A NARRATIVE REVIEW OF RECENT EVIDENCE

    EuroMediterranean Biomedical Journal

More on Coffee

Artificially sweetened beverages

no changein humans1

1 study
  1. Artificially sweetened beverages were not clearly linked with endometrial cancer in humans.

    “no statistically significant associations were found for artificially sweetened beverages (ASBs) or natural juices.”

    Humans13.3 yearsfemales

    Higher consumption of sugar-sweetened beverages is associated with an increased risk of endometrial cancer: a prospective cohort study of 92,777 women from the UK Biobank

    Frontiers in public health

More on Artificially sweetened beverages

Progestins

downin humans1

1 study
  1. Progestins prevent endometrial cancer in humans (balancing progestin with estrogen).

    “In women with a uterus, balancing progestin with estrogen is crucial to prevent endometrial cancer.”

    Reviewbalancing progestin with estrogenuterusfemales

    Progestins - a review of clinical application in gynecology

    Annals of medicine

More on Progestins

Butter

no changein humans1

1 study
  1. Butter was not clearly linked with endometrial cancer in humans (Iranian women).

    “No significant association was found between butter consumption and EC risk.”

    HumansIranian womenfemales

    Dairy products consumption linked to decreased risk of endometrial cancer: A case-control study

    Scientific reports

More on Butter

Sleep duration

no changein humans1OR 0.98

1 study
  1. Sleep duration showed no clear effect on endometrial cancer in humans (postmenopausal women) (OR 0.98, 95% CI 0.95–1.01 per 1-hour increment).

    “No associations were observed per 1-h increment of sleep”

    Reviewpostmenopausal womenper 1-h incrementfemales

    Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2)

    Sleep medicine reviews

More on Sleep duration

All 12

Effects

1

Falls

no changein humans1

1 study
  1. Endometrial cancer was not clearly linked with falls in humans (survivors vs noncancer group) (25% vs 26%; PR = 0.98; 95% CI: 0.89-1.08).

    “Fall prevalence was similar between groups (endometrial cancer: 25%; noncancer: 26%; PR = 0.98; 95% CI: 0.89-1.08).”

    Humanssurvivors vs noncancer groupfemales

    Falls, walking or balance problems, and limitations in activities of daily living (ADLs) among older endometrial cancer survivors

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Upstream

6

SLC9A7

upin humans1downin mice1

2 studies
  1. SLC9A7 protects against endometrial cancer in exogenous lactate-treated xenografts.

    “NHE7-overexpressing macrophages effectively abrogate exogenous lactate-accelerated xenograft tumor growth, as well as its M2 polarization and senescence.”

    Animalsin exogenous lactate-treated xenografts

    Lactate transmission from hypoxic tumor cells promotes macrophage senescence and M2 polarization via the DNMT1-NHE7 axis to accelerate endometrial cancer progression

    Cell death & disease

  2. SLC9A7 increases endometrial cancer in humans.

    “delays cell senescence and promotes cancer progression in vitro and in vivo.”

    Animals

    NHE7 drives endometrial cancer progression by delaying senescence through cAMP/CREB/GRIN2B axis-mediated Ca²⁺ influx

    Communications biology

More on SLC9A7

EPCAM

no changein humans1OR 0.76

1 study
  1. EPCAM was not clearly linked with endometrial cancer in humans (Isolated EPCAM 3' deletions relative to MGPT-negative individuals) (OR 0.76; P = .790).

    “but not endometrial cancer (OR, 0.76; P = .790).”

    HumansIsolated EPCAM 3' deletions relative to MGPT-negative individualsn = 96

    Redefining the EPCAM Phenotype: Deletion Architecture Determines Lynch Syndrome Cancer Risk

    JCO precision oncology

More on EPCAM

Body mass index

mediatesin humans1

1 study
  1. Body mass index is linked with endometrial cancer in humans (18.2% mediated).

    “body mass index (BMI) was found to mediate 18.2% of the association.”

    Humans13.3 yearsfemales

    Higher consumption of sugar-sweetened beverages is associated with an increased risk of endometrial cancer: a prospective cohort study of 92,777 women from the UK Biobank

    Frontiers in public health

More on Body mass index

Obesity-related traits

mediatesin humans1

1 study
  1. Obesity-related traits are linked with endometrial cancer in humans (relationship between age at menarche and endometrial cancer) (Mediating effects: BMI 55.54%; obesity 30.37%; waist circumference preference 27.67%; body fat percentage 17.61%; waist-to-hip ratio 14.82%).

    “Moreover, several obesity-related traits play a mediating role in the causal relationship between age at menarche and endometrial cancer.”

    Humansrelationship between age at menarche and endometrial cancer

    Causal Relationships Between Pregnancy, Menstrual History, and Endometrial Cancer With Mediating Effects of Metabolism-Related Traits

    Human mutation

Abdominal obesity

no changein humans1OR 1.21

1 study
  1. Abdominal obesity was not clearly linked with endometrial cancer in humans (Black women with BMI < 30 kg/m2) (OR 1.21, 95% CI 0.74–1.99).

    “Abdominal obesity among those with BMI < 30 kg/m2 was not appreciably associated with EC risk”

    HumansBlack women with BMI < 30 kg/m2females

    Risk factors for endometrial cancer in Black women

    Cancer causes & control : CCC

More on Abdominal obesity

Progesterone

no changein humans1HR 1.87

1 study
  1. Progesterone was not clearly linked with endometrial cancer in humans (postmenopausal women) (HR 1.87, 95% CI 0.85-4.11).

    “Circulating progesterone levels were not associated with endometrial [tertile (T)3 vs. T1 HR (95% confidence interval): 1.87 (0.85-4.11); P trend = 0.17] or ovarian cancer risk [1.16 (0.58-2.33); 0.73].”

    Humanspostmenopausal womenserum12 follow-up yearsfemales

    Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B∼FIT Cohort

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Progesterone

Associations

111

Bariatric surgery

downin humans4

4 studies
  1. Bariatric surgery is associated with endometrial cancer in humans (Individuals with obesity; compared with no surgery) (aIRR 0.51, 95% CI 0.45–0.59).

    “endometrial cancer (aIRR, 0.51; 95% CI, 0.45-0.59)”

    HumansIndividuals with obesity; compared with no surgery

    Weight-loss surgery linked to lower obesity-related cancer risk

    JAMA surgery

  2. Bariatric surgery lowers the risk of endometrial cancer in humans (durable metabolic correction).

    “Bariatric surgery offers the strongest human evidence supporting the principle that durable metabolic correction can substantially reduce EC incidence.”

    Reviewdurable metabolic correction

    Metabolic Amplification in Endometrial Carcinogenesis: Biological Rationale and Translational Limits of Precision Chemoprevention

    Biomedicines

  3. Bariatric surgery lowers the risk of endometrial cancer in patients with obesity/endometrial cancer.

    “weight-loss surgery has been proven to reduce the incidence and mortality of endometrial cancer”

    Reviewin patients with obesity/endometrial cancer

    The role and effects of metabolic and bariatric surgery on endometrial cancer care

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  4. Bariatric surgery lowers the risk of endometrial cancer in humans.

    “Bariatric surgery is the gold standard for successful weight loss and highlights how reversing of the systemic effects of obesity can reduce EC risk.”

    Review

    The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches

    Biochimica et biophysica acta. Reviews on cancer

More on Bariatric surgery

Body mass index

upin humans4HR 4.94

4 studies
  1. Body mass index is linked with a higher risk of endometrial cancer in humans (BMI >= 30 kg/m2 and top PRS tertile) (HR = 4.94 (95% CI 3.65-6.68)).

    “participants with a BMI ≥ 30 kg/m2 in the top PRS tertile showing the highest endometrial cancer risk (HR = 4.94; 95% CI 3.65-6.68)”

    HumansBMI >= 30 kg/m2 and top PRS tertilefemalesn = 129,829

    Risk stratification for endometrial cancer: independent and joint effects of polygenic risk score and body mass index in 129,829 UK Biobank participants

    BMC medicine

  2. Body mass index is associated with endometrial cancer in humans (Black women; BMI ≥ 40 versus < 25 kg/m2) (OR 3.92, 95% CI 2.91–5.27; BMI ≥ 40 versus < 25 kg/m2).

    “We observed a positive association between BMI and EC incidence (Ptrend < 0.0001)”

    HumansBlack women; BMI ≥ 40 versus < 25 kg/m2females

    Risk factors for endometrial cancer in Black women

    Cancer causes & control : CCC

  3. Body mass index is associated with endometrial cancer in humans.

    “increased BMI is associated with a higher risk of EC”

    Reviewfemales

    The Association Between Nutrition, Obesity, Inflammation, and Endometrial Cancer: A Scoping Review

    Current nutrition reports

  4. Body mass index is associated with endometrial cancer in humans (RR 1.54, 95% CI 1.47–1.61 per 5-unit BMI increase).

    “reaching relative risk (RR) 1.54 [95% confidence interval (CI) 1.47-1.61] per 5 unit increase for endometrial cancer”

    Reviewper 5 unit increase in BMI

    Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations

    Endocrine

More on Body mass index

Obesity

upin humans3OR 3.81

3 studies
  1. Obesity raises the risk of endometrial cancer in humans (site-specific meta-analysis) (OR 3.81, 1.08-13.45).

    “obesity with endometrial cancer (OR 3.81, 1.08-13.45)”

    Reviewsite-specific meta-analysis

    Modifiable lifestyle factors and cancer risk in Latin America: A systematic review with meta-analysis

    iScience

  2. Obesity is associated with endometrial cancer in humans.

    “Obesity is a well-known factor closely associated with the incidence and prognosis of endometrial lesions.”

    Review

    Tirzepatide for fertility-sparing treatment in obese/overweight patients with endometrial cancer and atypical hyperplasia: a phase II single-arm clinical trial protocol

    BMJ open

  3. Obesity raises the risk of endometrial cancer in humans.

    “Obesity is more tightly associated with EC than any other cancer.”

    Review

    The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches

    Biochimica et biophysica acta. Reviews on cancer

More on Obesity

Hormone replacement therapy

upin humans1downin humans1upin reviews1HR 0.49–1.499

3 studies
  1. Hormone replacement therapy is linked with a higher risk of endometrial cancer in humans (HR 1.499, 95% CI: 1.061-2.117).

    “MHT therapy use between three and six years was also associated with increased risk (HR 1.499, 95% CI: 1.061-2.117)”

    Humans3-6 yearsfemales

    Association between type and duration of menopausal hormone therapy and endometrial cancer risk: A population-based study

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

  2. Hormone replacement therapy is linked with a lower risk of endometrial cancer in humans (peri-menopausal women with pre-existing MASLD) (HR 0.49, 95% CI 0.40-0.61).

    “whilst endometrial cancer risk was reduced (0.49; 0.40, 0.61).”

    Humansperi-menopausal women with pre-existing MASLD5 yearsfemales

    Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri-Menopausal MASLD

    Liver international : official journal of the International Association for the Study of the Liver

  3. Hormone replacement therapy raises the risk of endometrial cancer (hedged as may be increased).

    “the risk of serous ovarian cancer and endometrial cancer may also be increased”

    Reviewhedged as may be increased

    European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer

    Molecular oncology

More on Hormone replacement therapy

GLP-1 receptor agonists

upin humans2downin humans1HR 0.34–1.55

3 studies
  1. GLP-1 receptor agonists are linked with a lower risk of endometrial cancer in women with endometrial hyperplasia or benign uterine pathology (HR 0.34, 95% CI 0.27-0.44).

    “GLP-1RA with progestins was associated with a significantly lower risk of EC compared with progestins only (HR, 0.34 [95% CI, 0.27-0.44]).”

    Humansin women with endometrial hyperplasia or benign uterine pathologyfemales

    GLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer Risk in Nonmalignant Uterine Diseases

    JAMA network open

  2. GLP-1 receptor agonists are linked with a higher risk of endometrial cancer in humans (compared with dipeptidyl peptidase 4 inhibitor users) (HR 1.55 (95% CI 1.01-2.37)).

    “revealed a significantly elevated endometrial cancer risk (HR, 1.55 [1.01-2.37])”

    Humanscompared with dipeptidyl peptidase 4 inhibitor usersn = 20,962

    Association of Glucagon-Like Peptide-1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

    Obesity (Silver Spring, Md.)

  3. GLP-1 receptor agonists are linked with a higher risk of endometrial cancer in humans (GLP-1RA vs. DPP4i comparison in matched cohort) (HR 1.55 (95% CI 1.01-2.37)).

    “revealed a significantly elevated endometrial cancer risk (HR, 1.55 [1.01-2.37])”

    HumansGLP-1RA vs. DPP4i comparison in matched cohortn = 20,962

    Association of Glucagon-Like Peptide 1 Receptor Agonists with Cancer Risk in Older Adults with Type 2 Diabetes

    ADA Scientific Sessions 2025 abstract

More on GLP-1 receptor agonists

Cadmium

upin humans2RR 1.22–1.27

2 studies
  1. Cadmium is associated with endometrial cancer in postmenopausal women (RR = 1.27, 95% CI: 0.99-1.64).

    “a marginally positive association was observed in postmenopausal women (RR = 1.27, 95% CI: 0.99-1.64)”

    Reviewin postmenopausal women

    Environmental endocrine disruptors and endometrial cancer risk: a systematic review and meta-analysis of cadmium and polychlorinated biphenyls, with emerging evidence on PFAS, phthalates, and bisphenols

    Frontiers in oncology

  2. Cadmium raises the risk of endometrial cancer in humans (RR = 1.22, 95% CI: 1.01-1.47).

    “higher cadmium exposure was associated with an increased risk of endometrial cancer (RR = 1.22, 95% CI: 1.01-1.47)”

    Review

    Environmental endocrine disruptors and endometrial cancer risk: a systematic review and meta-analysis of cadmium and polychlorinated biphenyls, with emerging evidence on PFAS, phthalates, and bisphenols

    Frontiers in oncology

  3. Cadmium raises the risk of endometrial cancer in humans (OR = 1.27, 95% CI: 1.07-1.50).

    “cadmium exposure was associated with an increased risk of endometrial cancer (OR = 1.27, 95% CI: 1.07-1.50”

    Review

    The Association Between Cadmium Exposure and Endometrial Cancer Risk: Evidence from a Comprehensive Updated Meta-Analysis

    Journal of clinical medicine

More on Cadmium

Type 2 diabetes

upin humans2HR 1.29–1.85

2 studies
  1. Type 2 diabetes is linked with a higher risk of endometrial cancer in humans (compared to adults without diabetes) (HR 1.29-1.85).

    “MOD and SIDD were associated with higher hazards of endometrial (HRs: 1.29 - 1.85) and ovarian cancers”

    Humanscompared to adults without diabetes10 yearsfemales

    Site-Specific Cancer Risk across Type 2 Diabetes Subtypes and Adults without Diabetes in a Real-World Cohort of 1.2 Million Adults

    ADA Scientific Sessions 2026 abstract

  2. Type 2 diabetes raises the risk of endometrial cancer in humans (independent of body mass index) (nearly doubled risk).

    “Endometrial cancer risk is nearly doubled in diabetic women, independent of body mass index”

    Reviewindependent of body mass indexfemales

    Impact of type 2 diabetes on malignancies of the female reproductive system

    Molecular aspects of medicine

More on Type 2 diabetes

Hysterectomy

upin humans1downin silico1−98%

2 studies
  1. Hysterectomy is associated with endometrial cancer in asymptomatic women undergoing hysterectomy for pelvic organ prolapse repair (0.3% (11/3588)).

    “11 cases (0.3%) of unexpected malignant postoperative endometrial pathology were identified.”

    Humansin asymptomatic women undergoing hysterectomy for pelvic organ prolapse repairfemalesn = 3,588

    Clinical characteristics for unexpected endometrial cancer following hysterectomy for pelvic organ prolapse repair

    Gynecology and Obstetrics Clinical Medicine

  2. Hysterectomy lowers the risk of endometrial cancer in female first-degree relatives with Lynch syndrome (-98%).

    “This strategy reduced the number of endometrial cancer cases to 5.4 (-98%), resulting in 516 quality-adjusted life years (QALY) gained”

    In silicoin female first-degree relatives with Lynch syndromefemalesn = 1,000

    Cost-effectiveness of prophylactic hysterectomy in first-degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study

    Cancer medicine

More on Hysterectomy

Estrogen

upin humans2HR 1.89

2 studies
  1. Estrogen raises the risk of endometrial cancer in humans (HR 1.89, 95% CI 1.55–2.31).

    “estrogen-only therapy significantly increased endometrial cancer risk (HR 1.89; 95% CI 1.55–2.31).”

    Reviewfemales

    Cardiovascular and Cancer Risks Associated with Different Hormone Replacement Therapy Regimens: A Systematic Review and Meta-Analysis (2020–2025 Evidence)

    Journal of medical & health sciences review.

  2. Estrogen raises the risk of endometrial cancer in humans (background literature).

    “estrogen-only HRT increases endometrial cancer risk”

    Reviewbackground literaturefemales

    Histological signatures of hormone replacement therapy in the endometrium

    Frontiers in medicine

More on Estrogen

Body mass index

upin humans2OR 1.89–5.57

2 studies
  1. Body mass index is linked with a higher risk of endometrial cancer in humans (OR 1.89; 95% CI: 1.69-2.11).

    “Body mass index (OR 1.89; 95% CI: 1.69-2.11)”

    Humans

    Association Between Educational Attainment and the Risk of Gynecological Malignancies: A Mediation Mendelian Randomization Study

    International journal of women's health

  2. Body mass index is linked with a higher risk of endometrial cancer in humans (BMI >=35 vs <25 kg/m2) (OR 5.57, 95% CI 4.33 to 7.16).

    “Body mass index was the strongest risk factor (OR≥35 vs<25 kg/m2 = 5.57, 95% CI = 4.33 to 7.16, for ages younger than 50 years”

    HumansBMI >=35 vs <25 kg/m2females

    Understanding risk factors for endometrial cancer in young women

    Journal of the National Cancer Institute

All 111

Trial sponsors

Funding

18 grants since 2016

National Cancer Institute$4.9MJapan Society for the Promotion of Science¥28.1MGouvernement du Canada | Canadian Institutes of Health ResearchCA$218K

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human cohort links higher biological-age measures with higher endometrial cancer risk; other human studies link later menopause and obesity with higher risk. Associations differ by hormone therapy: combined estrogen-progestogen is linked with lower risk, while estrogen-only use for at least five years is linked with higher risk in Black women.

  2. Summary rewritten as its findings changed.

    As it read before

    A human study links circadian syndrome to higher endometrial cancer risk; another links above-average childhood BMI to higher risk, while another reports no effect of lactation. An in silico Mendelian randomization analysis associates plasma phosphatidylcholine with endometrioid endometrial cancer.

  3. Summary written from the findings.

Latest

Dec 2025: 7Jan 2026: 26Feb 2026: 29Mar 2026: 16Apr 2026: 4May 2026: 7Jun 2026: 9Jul 2026: 7Aug 2026: 13Sep 2026: 13Oct 2026: 19Nov 2026: 9159 papers in 12 months
BJOG

Estrogen exposure estimates linked to longer life expectancy

At age 45, the highest total exposure category was linked to estimated life expectancy gains of 0.64 years in the UK cohort and 1.35 in the US.At age 45, the highest total exposure category was linked to estimated life expectancy gains of 0.64 years in the UK cohort and 1.35 in the US.

Cohort · 112,381 peoplePopulations

See all 346 papers on endometrial cancer